UCSF 19th Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2022

Include: 9 videos 2 pdfs, size: 5.82 GB
Target Audience: osteoporosis for physicians

Description

Include: 9 videos 2 pdfs, size: 5.82 GB

Now in its 19th year, and presented by the department of epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. Specific topics will include the cell biology of osteoporosis, bone biomechanics, endocrine and nutrition aspects of osteoporosis, and advances in skeletal imaging. The course will also critically review current treatment options and preview new treatments. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis.

TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for physicians and other clinicians working with osteoporosis patients. It will also benefit researchers, technologists and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. This year the conference will focus on the latest clinical updates and controversies about diagnosis and pharmacologic therapies. No prior clinical or scientific training in osteoporosis is required.

Educational Objectives

An attendee completing this course will be able to:

Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies, separately or in combination;
Assess the benefits and risks of long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
Perform a diagnostic evaluation of skeletal fragility when a congenital or acquired disorder other than osteoporosis is suspected;
Describe the approach to osteoporosis in the geriatric population;
Understand best practices and interpretation of dual-energy X-ray absorptiometry (DXA) scans.

Course Outline

Thursday, August 4, 2022
ANTIRESORPTIVE TREATMENT
8:00 AM	Zoom Registration and login, housekeeping, overview
8:10	Bisphosphonate Efficacy, Duration, and Drug Holidays: Maximize Benefits and Minimize Risk	Dennis M. Black, PhD
8:45	Q&A
8:55	Long-Term Treatment With and Following Denosumab	Richard Eastell, MD, FRCP
9:25	Q&A
9:35	Break
ANABOLIC TREATMENT
9:50	Accurate Diagnosis of Vertebral Fracture	Richard Eastell, MD, FRCP
10:10	Q&A
10:20	Anabolic Agents: Efficacy and Safety	Clifford J. Rosen, MD
10:55	Incorporating Anabolic Treatments into Osteoporosis Regimens	Anne L. Schafer, MD
11:25	Q&A
11:35	The Future of Osteoporosis Trials: FNIH-FDA Project	Dennis M. Black, PhD
11:55	Q&A
12:00 PM	Lunch Break
SPECIAL TOPICS IN OSTEOPOROSIS
1:00 PM	When is Skeletal Fragility Not Osteoporosis?
	Part 1: Acquired Causes of Skeletal Fragility	Deborah Sellmeyer, MD
1:25	Part 2: Genetic Causes of Skeletal Fragility	Edward Hsiao, MD, PhD
1:45	Q&A
1:55	Osteoporosis in the Geriatric Population	Deborah Kado, MD
2:20	Q&A
2:30	Break
2:40	DXA Interpretation and Pitfalls	Deborah Sellmeyer, MD
3:10	Q&A
3:20	Clinical Roundtable: Q&A with a Panel of Physicians	Deborah E. Sellmeyer, MD Anne L. Schafer, MD Clifford J. Rosen, MD Steven T. Harris, MD, FACP, FASBMR
3:50	Adjourn
RECORDED CONTENT
33:40:00	Basics of Bone Biology	Daniel Bikle, MD, PhD
33:30:00	Epidemiology and Consequences of Fractures	Ann V. Schwartz, PhD
40:44:00	Osteoporosis Screening and Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis	Steven T. Harris, MD, FACP, FASBMR
25:39:00	Calcium Intake	Anne L. Schafer, MD
41:47:00	Vitamin D	Clifford Rosen, MD
23:11	Physical Activity for Skeletal Health	Wendy L. Katzman, PT, DPTSc
45:00:00	Monitoring: Before, During and After Treatment	Doug C. Bauer, MD
35:57:00	Glucocorticoid-Induced Osteoporosis	Jonathan Graf, MD

Topics:

01 Basics of Bone Biology – Daniel Bikle, MD, PhD.mov
02 Epidemiology and Consequences of Fractures – Ann V. Schwartz, PhD.mov
03 Osteoporosis Screening and Diagnosis- BMD, FRAX and Assessment of Secondary Osteoporosis – Steven T. Harris, MD, FACP.mov
04 Calcium Intake – Anne L. Schafer, MD.mov
05 Vitamin D – Clifford Rosen, MD.mov
06 Physical Activity for Skeletal Health – Wendy L. Katzman, PT, DPTSc.mov
07 Monitoring Before, During and After Treatment.mp4
08 Glucocorticoid-Induced Osteoporosis – Jonathan Graf, MD.mov
August 4.ts
MEP23001_RecordedSyllabus.pdf
MEP23001_Syllabus.pdf

UCSF 19th Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2022

Related products

Login